To gain complimentary access to the January 2017 issue, please select the image above.

To access the journal home page, click here.

To access instructions for authors and related content, click here.

If you are a member and experiencing difficulty accessing the journal online, please email Michael Bonds [M.Bonds(a)elsevier.com)]. Michael is our society liaison and typically responds in under 24 hours. You may also email our Executive Director, Charles Metzger [cmetzger(a)srsweb.org].

Blog Index
The journal that this archive was targeting has been deleted. Please update your configuration.

Nuclear Medicine and Biology:
Official Journal of the SRS

Nuclear Medicine and Biology publishes original research addressing all aspects of radiopharmaceutical science: synthesis, in vitro and ex vivo studies, in vivo biodistribution by dissection or imaging, radiopharmacology, radiopharmacy, and translational clinical studies of new targeted radiotracers. The importance of the target to an unmet clinical need should be the first consideration. If the synthesis of a new radiopharmaceutical is submitted without in vitro or in vivo data, then the uniqueness of the chemistry must be emphasized.

July 2017 Issue (Vol. 50) Table of Contents

  • LogP, a yesterday's value?
    Chrysoula Vraka, Lukas Nics, Karl-Heinz Wagner, Marcus Hacker, Wolfgang Wadsak, Markus Mitterhauser 
  • Production of Zr-89 using sputtered yttrium coin targets 89Zr using sputtered yttrium coin targets
    Stacy Lee Queern, Tolulope Aramide Aweda, Adriana Vidal Fernandes Massicano, Nicholas Ashby Clanton, Retta El Sayed, Jayden Andrew Sader, Alexander Zyuzin, Suzanne Elizabeth Lapi 
  • Clinical usefulness of 18F–FDG PET/CT for initial staging and assessment of treatment efficacy in patients with lymph node tuberculosis
    Nicolas Lefebvre, Xavier Argemi, Nicolas Meyer, Joy Mootien, Nawal Douiri, Stefania Sferrazza-Mandala, Frédéric Schramm, Noëlle Weingertner, Daniel Christmann, Yves Hansmann, Alessio Imperiale 
  • Proton-induced production and radiochemical isolation of 44Ti from scandium metal targets for 44Ti/44Sc generator development
    Valery Radchenko, Jonathan W. Engle, Dmitri G. Medvedev, Joel M. Maassen, Cleo M. Naranjo, George A. Unc, Catherine A.L. Meyer, Tara Mastren, Mark Brugh, Leonard Mausner, Cathy S. Cutler, Eva R. Birnbaum, Kevin D. John, F. Meiring Nortier, Michael E. Fassbender 
  • Detection of melanoma metastases with PET—Comparison of 18F-5-FPN with 18F–FDG
    Yichun Wang, Mengting Li, Yingying Zhang, Fengzhen Zhang, Chunbao Liu, Yiling Song, Yongxue Zhang, Xiaoli Lan 
  • Radiosynthesis and biological evaluation of N-(2-[18F]fluoropropionyl)-3,4-dihydroxy-l-phenylalanine as a PET tracer for oncologic imaging
    Caihua Tang, Dahong Nie, Ganghua Tang, Siyuan Gao, Shaoyu Liu, Fuhua Wen, Xiaolan Tang 
  • Clinical results and economic considerations of 68Ga-PSMA and radiolabeled choline in prostate cancer
    Laura Evangelista, Maria Giuseppina Bonavina, Emilio Bombardieri